Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Paving new pathways

Jeffrey D Rothstein

    Nature Medicine
    |September 3, 2002
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Mutant SOD1 expressed by oligodendrocytes aggregates in myelinic nanochannels and accelerates disease progression in familial ALS mice.

    bioRxiv : the preprint server for biology·2026
    Same author

    Intrathecal (G<sub>4</sub>C<sub>2</sub>)<sub>149</sub> delivery in C9orf72-deficient mice yields mild motor dysfunction and ALS/FTD pathological hallmarks.

    Acta neuropathologica communications·2026
    Same author

    Is SORL1 a common genetic target across neurodegenerative diseases? A multi-ancestry biobank study.

    Brain : a journal of neurology·2026
    Same author

    Functional Activity of TDP-43: A Direct Biomarker for ALS.

    medRxiv : the preprint server for health sciences·2026
    Same author

    Intrathecal (G<sub>4</sub>C<sub>2</sub>)<sub>149</sub> delivery in C9orf72-deficient mice yields mild motor dysfunction and ALS/FTD pathological hallmarks.

    bioRxiv : the preprint server for biology·2026
    Same author

    Wild-type <i>C9orf72</i> expression is a genetic modifier of C9-ALS survival.

    medRxiv : the preprint server for health sciences·2026
    Same journal

    Generalizable AI predicts immunotherapy outcomes across cancers and treatments.

    Nature medicine·2026
    Same journal

    Immune aging biomarkers for clinical trials.

    Nature medicine·2026
    Same journal

    Lassa fever countermeasures gather pace.

    Nature medicine·2026
    Same journal

    Why high scores do not mean application readiness for health AI.

    Nature medicine·2026
    Same journal

    Polypill for heart failure with reduced ejection fraction: the POLY-HF randomized trial.

    Nature medicine·2026
    Same journal

    Biological aging might help to explain the rising risk of early-onset cancer.

    Nature medicine·2026
    See all related articles